Skip to content
healthcare.dev

Acyclovir

NDC 31722-681, Acyclovir, suspension, from Camber Pharmaceuticals, Inc..

Product NDC
31722-681
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215669
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-681 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACYCLOVIR200 mg/5mL

Pharmacologic classes

DNA Polymerase Inhibitors [MoA]; Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Nucleoside Analog [EXT]

Package NDCNDC-11Package
31722-681-4731722068147473 mL in 1 BOTTLE (31722-681-47)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2ca1395f-96b4-4543-8eed-bd07c62bbc7c
  • NADAC price for package 31722068147

    GET /v1/drugs/nadac/31722068147

Use it

Look up 31722-681 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-681 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-681. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.